We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Circadian Rhythms Strongly Influence Key Metabolic Pathways

By LabMedica International staff writers
Posted on 17 May 2012
By analyzing hundreds of metabolic products, researchers have discovered that circadian rhythms greatly control the production of such key building blocks as amino acids, carbohydrates, and lipids. More...
The findings also led to the world’s first comprehensive liver metabolite map.

Of the more than 600 liver-originated metabolites identified in the study, approximately 60% were found to be dependent on the endogenous circadian clock--many more than expected, as only about 15 % of the body’s known genes have been shown to be regulated by it.

This 24-hour biologic clock governs fundamental cellular processes and adapts certain bodily functions to the appropriate time of day. Disruption of these cycles can seriously affect human health. Dr. Paolo Sassone-Corsi, lead author of the study and director of the Center for Epigenetics & Metabolism at the University of California, Irvine (UCI; USA), reported that this investigation liver metabolites revealed how the clock--through the main circadian gene, CLOCK--orchestrates the interplay between metabolites and signaling proteins.

Since external cues, such as day-night lighting patterns and nutrition, influence the circadian machinery, metabolites and their relationship to signaling proteins seem to be acutely tied to circadian disruption and may be associated with primary factors underlying metabolic-based diseases like diabetes. “This interplay has far-reaching implications for human illness and aging, and it is likely vital for proper metabolism,” said Dr. Sassone-Corsi.

Working with scientists from Metabolon, Inc. (Durham, NC, USA; www.metabolon.com), Sassone-Corsi and Kristin Eckel-Mahan, a UCI postdoctoral researcher and study coauthor, created the first liver metabolome--a dataset of liver metabolites. With this information, they also partnered with Dr. Pierre Baldi, director of UCI’s Institute for Genomics & Bioinformatics, and his graduate student Vishal Patel to analyze the data and build CircadiOmics, a Web-based data system that provides detailed profiles of metabolites and related genes, and the underlying networks through which they interact. “Within CircadiOmics, we were able to integrate this circadian metabolite data with multiple other data sources to generate the first comprehensive map of the liver metabolome and its circadian oscillations, and to develop regulatory hypotheses that have been confirmed in the laboratory,” said Dr. Baldi.

The integrated map illustrates how the circadian metabolome, transcriptome, and proteome are connected through specific nodes that operate in concert to achieve metabolic homeostasis. “CircadiOmics is being expanded with metabolic data about other tissues and conditions, and will be invaluable to further our understanding of the interplay between metabolism and circadian rhythms in healthy and diseased states,” Dr. Baldi added.

The study appeared in the March, 2012, early online edition of the Proceedings of the [U.S.] National Academy of Sciences USA.

Related Links:

University of California at Irvine

Metabolon





Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.